Is the US biopharma industry headed for a turning point in 2017?
07 December 2016
Three months ago, Brent Saunders fired a shot across the bow of the USS Big Pharma, pledging to limit Allergan’s annual price increase on its portfolio drugs to no more than single-digit percentage hikes each year. On Monday, the new US president of diabetes specialist Novo Nordisk took that pledge. And 2017 is shaping up as a potential turning point in the heated public argument over drug prices in the US.
Small flu vax players poised to win 'sizable' share of market, firm predicts
06 December 2016
As new flu vaccine technology emerges in the coming years, smaller players will have a shot at stealing market share from the world leaders who have for years had a hold on the market.
EU health regulator warns some hep C drugs could reactivate hep B
05 December 2016
The European Medicines Agency warned on Friday that some of the most successful hepatitis C treatments on the market could reactivate hepatitis B in patients, the second time this year it has raised safety concerns over these treatments.
Influenza vaccine ‘desperately’ needs improvement
05 December 2016
The current seasonal influenza vaccine is not perfect, but experts agree that it remains the best available tool for fighting influenza — at least for now.
Pharma executives weigh in on possible changes under Trump
02 December 2016
Top executives from large U.S. drugmakers on Thursday discussed for the first time possible changes for the industry under President-elect Donald Trump, and issues that have damaged the reputation of their industry.
Biotech’s biggest protesters are turning into its supporters
02 December 2016
For decades the biotech industry has been hounded by activists over animal testing. Most notably, a campaign against Huntington Life Sciences in the late 1990s through 2000s included arson, harassment, threats and alleged fire bombings. Less severe, but still troubling for biotech, animal rights activists join with anti-GMOers most years to protest at the Biotechnology Innovation Organization (BIO) convention.
Immunization Administration and the Future of Pharmacy
01 December 2016
CDC officials report that more than 25% of influenza vaccines are administered by pharmacists. It would be safe to say that the immunization role of pharmacists has become an important public health success. The American Pharmacists Association (APhA) has more than 300,000 pharmacists trained as immunizers.
Pfizer Expands Humanitarian Assistance Program
01 December 2016
In a Nov. 11, 2016 press release Pfizer said that the company will be expanding its humanitarian assistance program allowing for broader access to the Prevenar 13 vaccine in humanitarian emergency settings. In situations where there is a need for humanitarian aid, Prevenar 13, a pneumococcal conjugate vaccine, will now be offered in a multi-dose vial for $3.10 per dose. During the first year of the expanded program, Pfizer said it will be donating all sales proceeds to humanitarian groups.
01 December 2016
Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos today announced a long-term collaboration aimed at improving the bioavailability, efficacy and safety profile of oral therapeutic medicines through nanotechnology. Potential benefits of research in this area include a reduction of adverse effects, increased patient adherence to treatment and more convenient dosing.
Contract research worth £192M a year to U.K. NHS, says KPMG
01 December 2016
Carrying out contract clinical research for life science companies injects around £192 million into the U.K. National Health Service every year in income and cost-savings, says a new report.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024
CRISPR technologies fuelling haematological innovations
17 April 2024
17 April 2024